The Supraoptic Nucleus (SON) is a critical hypothalamic structure composed of magnocellular neurosecretory neurons that synthesize and release vasopressin (arginine vasopressin, AVP) and oxytocin (OXT). These neurons represent one of the most prominent neuroendocrine systems in the brain, projecting their axons directly to the posterior pituitary gland where they release their peptide hormones into the systemic circulation.
The SON plays essential roles in maintaining body fluid homeostasis, regulating blood pressure, modulating social behaviors, and orchestrating stress responses. Dysfunction in SON neurons has been implicated in various neurological and neurodegenerative conditions.
| Property |
Value |
| Category |
Hypothalamic Neuroendocrine |
| Location |
Supraoptic nucleus, hypothalamus |
| Cell Types |
Vasopressin neurons, oxytocin neurons |
| Primary Neurotransmitter |
Peptide: Vasopressin, Oxytocin |
| Key Markers |
AVP, OXT, Neurophysin I, Neurophysin II |
¶ Anatomy and Connectivity
The SON is located in the anterior hypothalamus, immediately dorsal to the optic chiasm. It is paired (one on each side of the third ventricle) and constitutes one of the largest hypothalamic nuclei.
The SON contains approximately 2,000-3,000 magnocellular neurons in each hemisphere, divided into two main populations:
- Vasopressinergic neurons: ~60-70% of total neurons
- Oxytocineric neurons: ~30-40% of total neurons
The SON receives extensive inputs from:
- Organum vasculosum of the lamina terminalis (OVLT): Osmoreceptor information
- Median preoptic nucleus: Sodium and fluid balance
- Subfornical organ (SFO): Blood-borne signals
- Brainstem nuclei: Cardiovascular information
- Hippocampus: Behavioral state information
- Posterior pituitary: Primary neuroendocrine release site
- Median eminence: Secondary release site
- Extended amygdala: Behavioral modulation
- Bed nucleus of the stria terminalis (BNST): Stress integration
SON neurons exhibit characteristic electrophysiological features:
- Resting membrane potential: -60 to -70 mV
- Action potential duration: 1.5-3 ms
- Firing patterns:
- Phasic firing (vasopressin neurons)
- Continuous firing (oxytocin neurons)
- Burst firing (both types)
- Calcium dynamics: Plateau potentials, dendritic release
¶ Hormone Synthesis and Release
Both vasopressin and oxytocin are synthesized as preprohormones:
- Gene transcription: AVP or OXT gene
- Preprohormone processing: Cleavage to active peptide + neurophysin
- Axonal transport: To posterior pituitary terminals
- Activity-dependent release: Ca2+-triggered exocytosis
- Water reabsorption: Promotes water retention in kidneys
- Blood pressure: Vasoconstriction via V1 receptors
- Stress response: Modulates HPA axis activity
- Social behavior: Recognition, memory, aggression
- Milk ejection: Stimulates smooth muscle contraction in mammary glands
- Uterine contraction: Facilitates labor
- Social bonding: Pair attachment, trust, empathy
- Stress regulation: Reduces anxiety, attenuates stress responses
- Oxytocin deficits: Reduced OXT levels correlate with social memory impairment
- AVP changes: Altered vasopressin signaling in AD patients
- Circuit dysfunction: SON connectivity affected by neurodegeneration
- Behavioral symptoms: Agitation, anxiety linked to neuropeptide dysregulation
- Autonomic dysfunction: SON involvement in autonomic regulation
- Sleep disorders: AVP rhythm disruptions
- Mood alterations: Oxytocin system changes
- Central diabetes insipidus: AVP deficiency from SON damage
- Nephrogenic diabetes insipidus: AVP receptor defects
- Hyperphagia: Oxytocin neuron dysfunction
- Social deficits: Impaired oxytocin signaling
- Vasopressin analogs: Desmopressin (DDAVP) for central diabetes insipidus
- Oxytocin therapy: Intranasal OXT for social cognition deficits
- V1a/V1b receptor antagonists: For stress-related disorders
- Gene therapy: AAV-mediated AVP/OXT delivery
- Neuropeptide agonists: Selective receptor targeting
- Stem cell therapy: Potential for SON regeneration
- Electrophysiology: Patch-clamp recordings, extracellular unit recordings
- Optogenetics: Channelrhodopsin-based manipulation
- Fiber photometry: Real-time neuropeptide release monitoring
- Molecular biology: Gene expression analysis, CRISPR editing
- Behavioral testing: Social behavior, fluid balance assays
The study of Supraoptic Nucleus Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Russell JA, et al. Supraoptic nucleus. Prog Brain Res. 2002;139:85-93.
- Brown CH, et al. Electrophysiology of supraoptic neurons. Exp Neurol. 2012;237(2):159-173.
- Ludwig M, et al. Dendritic release of neuropeptides. Physiol Rev. 2012;92(4):1813-1864.
- Sobrapi T, et al. Vasopressin and oxytocin in stress. Nat Rev Neurosci. 2013;14(5):299-312.
- Neumann ID, et al. Brain oxytocin. Nat Rev Neurosci. 2015;16(7):383-395.
- Raggenbass M, et al. Vasopressin receptors. Pharmacol Rev. 2015;67(3):573-620.
- Landgraf R, Neumann ID. Vasopressin and oxytocin. Neuroscience. 2014;256:216-230.
- Althammer F, et al. Optogenetic manipulation of SON neurons. J Neurosci. 2018;38(23):5354-5368.